Chairman Liu Qiang of EGing Photovoltaic Technology (600537.SH) resigns.
Trina Solar (600537.SH) announced that the company's board of directors received notices from Liu Qiang, Sun Tiedun...
EGing Photovoltaic Technology (600537.SH) Announcement: The Company's board of directors received written resignation reports from Liu Qiang, Sun Tiedun, and Zhang Ting on January 6, 2025. Liu Qiang has applied to resign from his positions as non-independent director, chairman of the board of the eighth board of directors, member of the Strategic Development and ESG Committee, and member of the Nomination Committee due to work reasons. After resigning, Liu Qiang will continue to serve as the company's general manager. Sun Tiedun has applied to resign from his positions as non-independent director and member of the Strategic Development and ESG Committee of the eighth board of directors due to work reasons. After resigning, Sun Tiedun will continue to serve as the company's vice general manager. Zhang Ting has applied to resign from her positions as non-independent director and member of the Remuneration and Assessment Committee of the eighth board of directors due to work reasons. After resigning, Zhang Ting will continue to serve as the company's vice general manager.
Related Articles

Outlook for the US stock market in the third quarter of 2025 from CITIC Securities: The fundamentals still have resilience, short-term disturbances do not change the upward trend.

Tengshi and Fancheng Leopard continue to be bestsellers. BYD Company Limited (01211) high-end transformation welcomes "acceleration".

China's Outlook on Biopharmaceuticals in 2026: Innovation as the Theme, Breaking Through Overseas Markets and Commercial Insurance.
Outlook for the US stock market in the third quarter of 2025 from CITIC Securities: The fundamentals still have resilience, short-term disturbances do not change the upward trend.

Tengshi and Fancheng Leopard continue to be bestsellers. BYD Company Limited (01211) high-end transformation welcomes "acceleration".

China's Outlook on Biopharmaceuticals in 2026: Innovation as the Theme, Breaking Through Overseas Markets and Commercial Insurance.

RECOMMEND

Short Positions on Xiaomi (01810.HK) Surge 53% in a Week as Memory Price Spike Weighs on Sentiment
07/11/2025

Privatization Wave in Hong Kong Stocks: Exiting Liquidity Traps to Enable Strategic Transformation
07/11/2025

Over 30 Foreign Firms Attend Roundtable as Ministry of Commerce Signals Multiple Policy Shifts
07/11/2025


